Levprot Bioscience at ADLM 2024: Showcasing Innovations in Chicago
We are pleased to have attended ADLM 2024 in Chicago, where Levprot Bioscience had the opportunity to showcase its latest advancements in recombinant proteins, enzymes, and CDMO services. This prestigious event provided an excellent platform to connect with professionals in the clinical diagnostics and life sciences industries, exchange insights, and explore potential collaborations.
Engaging with Experts
Our team, including Matilde de las Rivas, Ángela García, and Sandra Bosch Reñe, PhD, was available at our booth to discuss our innovative solutions and how they contribute to biotechnological research and applications. We had insightful conversations with attendees looking for custom protein development, enzyme production, and bioprocessing solutions, and we were thrilled to share our expertise.
Highlights from Our Booth
- Comprehensive Product Portfolio: We showcased our latest recombinant proteins and enzymes, designed for high-performance applications.
- Custom Development & Manufacturing (CDMO) Services: Attendees learned about our tailor-made bioproduction solutions.
- Networking & Scientific Exchange: Engaging discussions on the latest trends in biotechnology and protein engineering took place throughout the event.
Thank You for Joining Us at ADLM 2024
We extend our gratitude to all who visited our stand and took the time to discuss how Levprot Bioscience is driving innovation in biotechnology. Your interest and collaboration are key to shaping the future of diagnostics, pharmaceuticals, and industrial biotech.
We look forward to staying connected and continuing these exciting conversations. See you at future events!